Grant of Interim Extension of the Term of U.S. Patent No. 6,929,639-POLARX® (Cryoablation Balloon Catheter), 14149 [2023-04661]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 44 / Tuesday, March 7, 2023 / Notices
DEPARTMENT OF COMMERCE
United States Patent and Trademark
Office
[Docket No. PTO–P–2023–0007]
Grant of Interim Extension of the Term
of U.S. Patent No. 6,929,639—
POLARX® (Cryoablation Balloon
Catheter)
will continue beyond the original
expiration date of the patent, March 16,
2023, interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
6,929,639 is granted for a period of one
year from the original expiration date of
the patent.
Robert Bahr,
Deputy Commissioner for Patents, United
States Patent and Trademark Office.
United States Patent and
Trademark Office, Commerce.
ACTION: Notice of interim patent term
extension.
AGENCY:
[FR Doc. 2023–04661 Filed 3–6–23; 8:45 am]
BILLING CODE 3510–16–P
The United States Patent and
Trademark Office has issued a
certificate under 35 U.S.C. 156(d)(5) for
a one-year interim extension of the term
of U.S. Patent No. 6,929,639.
FOR FURTHER INFORMATION CONTACT:
Andrea Grossman, Legal Advisor
(telephone (571) 270–3314; email
andrea.grossman@uspto.gov) or
Kathleen Kahler Fonda, Senior Legal
Advisor (telephone (571) 272–7754;
email kathleen.fonda@uspto.gov).
Alternatively, mail may be addressed to
Commissioner for Patents, Mail Stop
Hatch-Waxman PTE, P.O. Box 1450,
Alexandria, VA, 22313–1450, and
marked to the attention of Ms. Grossman
or Ms. Fonda.
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On February 10, 2023, Boston
Scientific Scimed, Inc., the patent
owner of record, timely filed an
application under 35 U.S.C. 156(d)(5)
for an interim extension of the term of
U.S. Patent No. 6,929,639. The patent
claims a cryoablation balloon catheter,
POLARX®. The application for patent
term extension indicates that Premarket
Approval Application P220032 was
submitted to the Food and Drug
Administration on December 20, 2022.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:49 Mar 06, 2023
Jkt 259001
COMMITTEE FOR THE
IMPLEMENTATION OF TEXTILE
AGREEMENTS
Request for Public Comment on a
Commercial Availability Request Under
the U.S.-Chile Free Trade Agreement
The Committee for the
Implementation of Textile Agreements
(CITA).
ACTION: Request for public comments.
AGENCY:
In June 2015, the Government
of the United States received a request
from the Government of Chile to modify
the U.S.-Chile Free Trade Agreement
(FTA) rules of origin for woven fabrics
of artificial filament yarn in
subheadings 5408.22–5408.23 of the
Harmonized Tariff Schedule of the
United States (HTSUS) to allow the use
of non-U.S. or Chilean filament yarn of
viscose rayon classified in subheadings
5403.10, 5403.31, 5403.32, and 5403.41
of the HTSUS. In July 2015, CITA
solicited public comments on this
request, in particular with regard to
whether filament yarn of viscose rayon
classified in subheadings 5403.10,
5403.31, 5403.32, and 5403.41 can be
supplied by the domestic industry in
commercial quantities in a timely
manner. No information was received at
that time indicating that domestic
industry could supply the subject yarns.
Subsequently, the United States and
Chile have continued to consult
regarding the subject rule change. In
November 2022, the Government of
Chile reiterated its interest in advancing
the subject rule change. Given the
period of time that has elapsed since
CITA initially solicited public
comments on this request, CITA is again
soliciting public comments to determine
if the subject yarns can be supplied by
the domestic industry in commercial
quantities in a timely manner. The
President may proclaim a modification
to the U.S.-Chile FTA rules of origin
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
14149
only after reaching an agreement with
Chile on the modification and after
other domestic processes are completed
to implement the modification.
DATES: Comments must be submitted by
April 6, 2023.
ADDRESSES: Submit comments to the
Chairman, Committee for the
Implementation of Textile Agreements,
Room 30003, United States Department
of Commerce, Washington, DC 20230.
Public versions of such comments may
be submitted electronically to otexa@
trade.gov. Interested persons who wish
to submit business confidential
information electronically should
contact Laurie.Mease@trade.gov for
instructions for secure online
submission.
FOR FURTHER INFORMATION CONTACT:
Laurie Mease, International Trade
Specialist, Office of Textiles and
Apparel, U.S. Department of Commerce,
(202) 482–2043 or Laurie.Mease@
trade.gov.
SUPPLEMENTARY INFORMATION:
Authority: Section 204 of the
Agricultural Act of 1956, as amended (7
U.S.C. 1854); Executive Order 11651 of
March 3, 1972, as amended; Section 202
of the U.S.-Chile Free Trade Agreement
Implementation Act (19 U.S.C. 3805).
Background
Under the U.S.-Chile Free Trade
Agreement (FTA), each country is
required to eliminate customs duties on
textile and apparel goods that qualify as
originating goods under the FTA rules
of origin, which are set out in Annex 4.1
to the FTA. Article 3.20 of the FTA
provides that the rules of origin for
textile and apparel products may be
amended through a subsequent
agreement between the two countries
under certain circumstances. In the
consultations regarding such a change,
the two countries are to consider issues
of availability of fibers, yarns, or fabrics
in the free trade area and whether
domestic producers are capable of
supplying commercial quantities of the
good in a timely manner. Section 202 of
the U.S.-Chile FTA Implementation Act
provides the President with the
authority to proclaim modifications to
the FTA rules of origin as are necessary
to implement an agreement with Chile
on such a modification.
In June 2015, the Government of the
United States received a request for
consultations from the Government of
Chile for the purpose of considering
whether the FTA rules of origin for
woven fabrics of artificial filament yarn
in subheadings 5408.22–5408.23 of the
HTSUS should be modified to allow the
use of non-U.S. or Chilean filament yarn
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 88, Number 44 (Tuesday, March 7, 2023)]
[Notices]
[Page 14149]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04661]
[[Page 14149]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
United States Patent and Trademark Office
[Docket No. PTO-P-2023-0007]
Grant of Interim Extension of the Term of U.S. Patent No.
6,929,639--POLARX[supreg] (Cryoablation Balloon Catheter)
AGENCY: United States Patent and Trademark Office, Commerce.
ACTION: Notice of interim patent term extension.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office has issued a
certificate under 35 U.S.C. 156(d)(5) for a one-year interim extension
of the term of U.S. Patent No. 6,929,639.
FOR FURTHER INFORMATION CONTACT: Andrea Grossman, Legal Advisor
(telephone (571) 270-3314; email [email protected]) or Kathleen
Kahler Fonda, Senior Legal Advisor (telephone (571) 272-7754; email
[email protected]). Alternatively, mail may be addressed to
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450,
Alexandria, VA, 22313-1450, and marked to the attention of Ms. Grossman
or Ms. Fonda.
SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code,
generally provides that the term of a patent may be extended for a
period of up to five years if the patent claims a product, or a method
of making or using a product, that has been subject to certain defined
regulatory review, and that the patent may be extended for interim
periods of up to one year if the regulatory review is anticipated to
extend beyond the expiration date of the patent.
On February 10, 2023, Boston Scientific Scimed, Inc., the patent
owner of record, timely filed an application under 35 U.S.C. 156(d)(5)
for an interim extension of the term of U.S. Patent No. 6,929,639. The
patent claims a cryoablation balloon catheter, POLARX[supreg]. The
application for patent term extension indicates that Premarket Approval
Application P220032 was submitted to the Food and Drug Administration
on December 20, 2022.
Review of the patent term extension application indicates that,
except for permission to market or use the product commercially, the
subject patent would be eligible for an extension of the patent term
under 35 U.S.C. 156, and that the patent should be extended for one
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory
review period will continue beyond the original expiration date of the
patent, March 16, 2023, interim extension of the patent term under 35
U.S.C. 156(d)(5) is appropriate.
An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S.
Patent No. 6,929,639 is granted for a period of one year from the
original expiration date of the patent.
Robert Bahr,
Deputy Commissioner for Patents, United States Patent and Trademark
Office.
[FR Doc. 2023-04661 Filed 3-6-23; 8:45 am]
BILLING CODE 3510-16-P
